Breaking News Instant updates and real-time market news.

MBRX

Moleculin Biotech

$1.92 /

+ (+0.00%)

08:55
04/21/22
04/21
08:55
04/21/22
08:55

Moleculin Biotech receives IND clearance for Phase 1 study of glioma candidate

Moleculin Biotech announced that the FDA is allowing the company's Investigational New Drug application to study WP1066 for the treatment of recurrent malignant glioma. With this IND now cleared, Moleculin plans to evaluate strategic partnerships and collaborations to conduct a Phase 1 open label, single arm, dose escalation study of the safety, pharmacokinetics and efficacy of oral WP1066 in adult patients with recurrent malignant glioma. WP1066 is the company's flagship Immune/Transcription Modulator designed to stimulate the immune response to tumors by inhibiting the errant activity of Regulatory T-Cells while also inhibiting key oncogenic transcription factors. These transcription factors are widely sought targets that are believed to contribute to an increase in cell survival and proliferation. WP1066 is currently being evaluated for the treatment of pediatric brain tumors. The company has received Orphan Drug Designation for WP1066 for the treatment of brain tumors, as well as Rare Pediatric Disease designation for three other pediatric indications. Additionally, WP1066 + radiation is being evaluated, pre-clinically, in the treatment of Glioblastoma Multiforme. Glioma is a common type of tumor originating in the brain. About 33% of all brain tumors are gliomas.

  • 26

    May

OTHER BREAKING NEWS FROM THE FLY

Periodicals
Microsoft says Xbox One sold less than half as many units as PS4, Verge says » 12:03
08/15/22
08/15
12:03
08/15/22
12:03
MSFT

Microsoft

$292.47 /

+0.6 (+0.21%)

, SONY

Sony

$86.95 /

+0.195 (+0.22%)

, ATVI

Activision Blizzard

$80.53 /

-0.22 (-0.27%)

Microsoft (MSFT) told…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MSFT Microsoft
$292.47 /

+0.6 (+0.21%)

SONY Sony
$86.95 /

+0.195 (+0.22%)

ATVI Activision Blizzard
$80.53 /

-0.22 (-0.27%)

MSFT Microsoft
$292.47 /

+0.6 (+0.21%)

08/11/22 Guggenheim
Microsoft initiated with a Neutral at Guggenheim
08/08/22 B. Riley
B. Riley thinks Globalstar's mystery satellite capacity customer is Apple
08/04/22 MKM Partners
8x8 initiated with a Neutral at MKM Partners
08/04/22 Deutsche Bank
Activision Blizzard price target lowered to $84 from $95 at Deutsche Bank
SONY Sony
$86.95 /

+0.195 (+0.22%)

07/08/22 Macquarie
Sony upgraded to Outperform, added to 'Marquee Buy' list at Macquarie
07/05/22 Citi
Sony downgraded to Neutral from Buy at Citi
05/18/22 Oppenheimer
Sony price target lowered to $125 from $150 at Oppenheimer
04/13/22 CLSA
Sony downgraded to Outperform from Buy at CLSA
ATVI Activision Blizzard
$80.53 /

-0.22 (-0.27%)

08/04/22 Deutsche Bank
Activision Blizzard price target lowered to $84 from $95 at Deutsche Bank
07/25/22 MoffettNathanson
Activision Blizzard upgraded to Outperform at MoffettNathanson
05/31/22 Benchmark
Marcus, Imax, WWE added to entertainment top ideas list at Benchmark
05/06/22 Benchmark
Playstudios could still be target as industry consolidates, says Benchmark
MSFT Microsoft
$292.47 /

+0.6 (+0.21%)

SONY Sony
$86.95 /

+0.195 (+0.22%)

ATVI Activision Blizzard
$80.53 /

-0.22 (-0.27%)

MSFT Microsoft
$292.47 /

+0.6 (+0.21%)

SONY Sony
$86.95 /

+0.195 (+0.22%)

ATVI Activision Blizzard
$80.53 /

-0.22 (-0.27%)

MSFT Microsoft
$292.47 /

+0.6 (+0.21%)

SONY Sony
$86.95 /

+0.195 (+0.22%)

ATVI Activision Blizzard
$80.53 /

-0.22 (-0.27%)

MSFT Microsoft
$292.47 /

+0.6 (+0.21%)

ATVI Activision Blizzard
$80.53 /

-0.22 (-0.27%)

Hot Stocks
Holland America Line simplifies COVID-19 procedures » 12:03
08/15/22
08/15
12:03
08/15/22
12:03
CCL

Carnival

$10.75 /

+0.04 (+0.37%)

, CUK

Carnival plc

$9.79 /

+0.04 (+0.41%)

Holland America Line is…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CCL Carnival
$10.75 /

+0.04 (+0.37%)

CUK Carnival plc
$9.79 /

+0.04 (+0.41%)

CCL Carnival
$10.75 /

+0.04 (+0.37%)

07/22/22 Truist
Carnival price target lowered to $8 from $15 at Truist
07/21/22 Stifel
Carnival selloff 'coming for sure' as equity raise will cause panic, says Stifel
07/04/22 HSBC
HSBC says too early to call inflection point for Carnival
06/29/22 Morgan Stanley
Morgan Stanley cuts Carnival price target to $7, sees bear case of zero
CUK Carnival plc
$9.79 /

+0.04 (+0.41%)

08/10/22 UBS
Carnival plc price target raised to 884 GBp from 878 GBp at UBS
07/21/22 Stifel
Carnival selloff 'coming for sure' as equity raise will cause panic, says Stifel
06/29/22 Morgan Stanley
Morgan Stanley cuts Carnival price target to $7, sees bear case of zero
04/04/22 UBS
Carnival plc price target raised to 1,537 GBp from 1,422 GBp at UBS
CCL Carnival
$10.75 /

+0.04 (+0.37%)

  • 21
    Jul
CCL Carnival
$10.75 /

+0.04 (+0.37%)

CCL Carnival
$10.75 /

+0.04 (+0.37%)

CCL Carnival
$10.75 /

+0.04 (+0.37%)

Initiation
Haleon initiated with a Sector Perform at RBC Capital » 12:01
08/15/22
08/15
12:01
08/15/22
12:01
HLN

Haleon

$6.35 /

-0.345 (-5.15%)

, PFE

Pfizer

$49.55 /

-0.55 (-1.10%)

, GSK

GSK plc

$34.55 /

-1.495 (-4.15%)

RBC Capital analyst James…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
HLN Haleon
$6.35 /

-0.345 (-5.15%)

PFE Pfizer
$49.55 /

-0.55 (-1.10%)

GSK GSK plc
$34.55 /

-1.495 (-4.15%)

HLN Haleon
$6.35 /

-0.345 (-5.15%)

08/12/22 JPMorgan
Sanofi may not be liable for any Zantac litigation damages, says JPMorgan
08/11/22 JPMorgan
Perrigo, Pfizer appear to have manageable Zantac exposure, says JPMorgan
08/11/22 Deutsche Bank
Zantac cases likely a short-term headwind for GSK, Sanofi, says Deutsche Bank
07/29/22 Deutsche Bank
Haleon initiated with a Hold at Deutsche Bank
PFE Pfizer
$49.55 /

-0.55 (-1.10%)

08/14/22 BofA
Pfizer Prevnar-20 miss on co-primary endpoint could help Vaxcyte, says BofA
08/12/22 JPMorgan
Sanofi may not be liable for any Zantac litigation damages, says JPMorgan
08/11/22 JPMorgan
Perrigo, Pfizer appear to have manageable Zantac exposure, says JPMorgan
08/11/22 Deutsche Bank
Zantac cases likely a short-term headwind for GSK, Sanofi, says Deutsche Bank
GSK GSK plc
$34.55 /

-1.495 (-4.15%)

10:20 Today Stifel
Ideaya Biosciences downgraded to Hold at Stifel after GSK waives IDE397 opt-in
08/12/22 JPMorgan
Sanofi may not be liable for any Zantac litigation damages, says JPMorgan
08/11/22 JPMorgan
Perrigo, Pfizer appear to have manageable Zantac exposure, says JPMorgan
08/11/22 Deutsche Bank
Zantac cases likely a short-term headwind for GSK, Sanofi, says Deutsche Bank
PFE Pfizer
$49.55 /

-0.55 (-1.10%)

GSK GSK plc
$34.55 /

-1.495 (-4.15%)

HLN Haleon
$6.35 /

-0.345 (-5.15%)

PFE Pfizer
$49.55 /

-0.55 (-1.10%)

GSK GSK plc
$34.55 /

-1.495 (-4.15%)

HLN Haleon
$6.35 /

-0.345 (-5.15%)

PFE Pfizer
$49.55 /

-0.55 (-1.10%)

GSK GSK plc
$34.55 /

-1.495 (-4.15%)

HLN Haleon
$6.35 /

-0.345 (-5.15%)

PFE Pfizer
$49.55 /

-0.55 (-1.10%)

GSK GSK plc
$34.55 /

-1.495 (-4.15%)

Recommendations
Russel Metals price target raised to C$42 from C$39 at RBC Capital » 12:01
08/15/22
08/15
12:01
08/15/22
12:01
RUSMF

Russel Metals

$23.20 /

+0.67 (+2.97%)

RBC Capital analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
RUSMF Russel Metals
$23.20 /

+0.67 (+2.97%)

11:09 Today Scotiabank
Russel Metals price target lowered to C$37.50 from C$38.50 at Scotiabank
08/12/22 BMO Capital
Russel Metals price target lowered to C$32 from C$36 at BMO Capital
08/12/22 Stifel
Russel Metals price target raised to C$40 from C$34 at Stifel
07/18/22 RBC Capital
Russel Metals price target lowered to C$39 from C$45 at RBC Capital
Conference/Events
Cantor Fitzgerald equity derivative analyst has analyst/industry conference call » 12:01
08/15/22
08/15
12:01
08/15/22
12:01

Equity Derivatives and…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Recommendations
Northland Power price target raised to C$48 from C$46 at RBC Capital » 12:01
08/15/22
08/15
12:01
08/15/22
12:01
NPIFF

Northland Power

$35.76 /

+1.22 (+3.53%)

RBC Capital analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
NPIFF Northland Power
$35.76 /

+1.22 (+3.53%)

NPIFF Northland Power
$35.76 /

+1.22 (+3.53%)

11:30 Today National Bank
Northland Power price target raised to C$49 from C$47 at National Bank
11:04 Today Scotiabank
Northland Power price target raised to C$51 from C$46.25 at Scotiabank
10:53 Today TD Securities
Northland Power price target raised to C$55 from C$47 at TD Securities
08/12/22 BMO Capital
Northland Power price target raised to C$50 from C$44 at BMO Capital
Recommendations
MDA Ltd price target lowered to C$13 from C$15 at RBC Capital » 12:01
08/15/22
08/15
12:01
08/15/22
12:01
MDALF

MDA Ltd

/

+

RBC Capital analyst Ken…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MDALF MDA Ltd
/

+

MDALF MDA Ltd
/

+

05/12/22 BMO Capital
MDA Ltd price target lowered to C$11 from C$13 at BMO Capital
05/12/22 Canaccord
MDA Ltd price target lowered to C$15 from C$20 at Canaccord
03/18/22 Canaccord
MDA Ltd price target lowered to C$20 from C$21 at Canaccord
03/18/22 RBC Capital
MDA Ltd price target raised to C$15 from C$13 at RBC Capital
Recommendations
H&R REIT price target raised to C$15.75 from C$15 at RBC Capital » 12:00
08/15/22
08/15
12:00
08/15/22
12:00
HRUFF

H&R REIT

$10.86 /

+0.21 (+1.97%)

RBC Capital analyst Matt…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
HRUFF H&R REIT
$10.86 /

+0.21 (+1.97%)

11:37 Today National Bank
H&R REIT price target raised to C$16.50 from C$15.25 at National Bank
07/20/22 National Bank
H&R REIT price target lowered to C$15.25 from C$18.50 at National Bank
05/18/22 Scotiabank
H&R REIT price target raised to C$16.50 from C$15.25 at Scotiabank
05/16/22 BMO Capital
H&R REIT price target raised to C$18 from C$16 at BMO Capital
Hot Stocks
Redwire falls -9.9% » 12:00
08/15/22
08/15
12:00
08/15/22
12:00
RDW

Redwire

$3.57 /

-0.35 (-8.93%)

Redwire is down -9.9%, or…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
RDW Redwire
$3.57 /

-0.35 (-8.93%)

RDW Redwire
$3.57 /

-0.35 (-8.93%)

09/28/21
Fly Intel: Top five analyst initiations
09/28/21 Jefferies
Redwire initiated with a Buy at Jefferies
RDW Redwire
$3.57 /

-0.35 (-8.93%)

RDW Redwire
$3.57 /

-0.35 (-8.93%)

RDW Redwire
$3.57 /

-0.35 (-8.93%)

Hot Stocks
Turquoise Hill falls -10.4% » 12:00
08/15/22
08/15
12:00
08/15/22
12:00
TRQ

Turquoise Hill

$23.56 /

-2.68 (-10.21%)

Turquoise Hill is down…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TRQ Turquoise Hill
$23.56 /

-2.68 (-10.21%)

TRQ Turquoise Hill
$23.56 /

-2.68 (-10.21%)

08/08/22 Canaccord
Turquoise Hill price target lowered to C$42 from C$44 at Canaccord
08/08/22 TD Securities
Turquoise Hill price target lowered to C$38 from C$40 at TD Securities
08/08/22 Canaccord
Turquoise Hill price target lowered to C$42 from C$44 at Canaccord
07/14/22 Canaccord
Turquoise Hill price target lowered to C$44 from C$45 at Canaccord
TRQ Turquoise Hill
$23.56 /

-2.68 (-10.21%)

TRQ Turquoise Hill
$23.56 /

-2.68 (-10.21%)

Hot Stocks
SmartRent falls -13.2% » 12:00
08/15/22
08/15
12:00
08/15/22
12:00
SMRT

SmartRent

$3.32 /

-0.495 (-12.99%)

SmartRent is down -13.2%,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SMRT SmartRent
$3.32 /

-0.495 (-12.99%)

SMRT SmartRent
$3.32 /

-0.495 (-12.99%)

08/12/22 Cantor Fitzgerald
SmartRent price target lowered to $5.25 from $6.00 at Cantor Fitzgerald
07/22/22 Cantor Fitzgerald
SmartRent assumed with an Overweight at Cantor Fitzgerald
07/19/22 Keefe Bruyette
Bain Capital sold 5% of stake in SmartRent, says Keefe Bruyette
05/25/22 Compass Point
Compass Point starts SmartRent at Buy, sees 'exponential growth potential'
SMRT SmartRent
$3.32 /

-0.495 (-12.99%)

SMRT SmartRent
$3.32 /

-0.495 (-12.99%)

Hot Stocks
Enhabit rises 16.0% » 12:00
08/15/22
08/15
12:00
08/15/22
12:00
EHAB

Enhabit

$16.08 /

+2.27 (+16.44%)

Enhabit is up 16.0%, or…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
EHAB Enhabit
$16.08 /

+2.27 (+16.44%)

EHAB Enhabit
$16.08 /

+2.27 (+16.44%)

08/08/22 Truist
Encompass Health price target lowered to $65 from $75 at Truist
07/13/22 BofA
BofA starts Enhabit at Underperform on Medicare rate risks
07/13/22 BofA
Enhabit initiated with an Underperform at BofA
EHAB Enhabit
$16.08 /

+2.27 (+16.44%)

EHAB Enhabit
$16.08 /

+2.27 (+16.44%)

Hot Stocks
Blue Apron rises 20.7% » 12:00
08/15/22
08/15
12:00
08/15/22
12:00
APRN

Blue Apron

$4.60 /

+0.795 (+20.89%)

Blue Apron is up 20.7%,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
APRN Blue Apron
$4.60 /

+0.795 (+20.89%)

APRN Blue Apron
$4.60 /

+0.795 (+20.89%)

08/10/22 Lake Street
Blue Apron initiated with a Buy at Lake Street
07/20/22 Benchmark
Benchmark starts Blue Apron at Buy with turnaround not getting credit
07/20/22 Benchmark
Blue Apron initiated with a Buy at Benchmark
05/10/22 Canaccord
Blue Apron price target lowered to $10 from $12 at Canaccord
APRN Blue Apron
$4.60 /

+0.795 (+20.89%)

APRN Blue Apron
$4.60 /

+0.795 (+20.89%)

APRN Blue Apron
$4.60 /

+0.795 (+20.89%)

APRN Blue Apron
$4.60 /

+0.795 (+20.89%)

Hot Stocks
Revlon rises 22.6% » 12:00
08/15/22
08/15
12:00
08/15/22
12:00
REV

Revlon

$8.05 /

+1.48 (+22.53%)

Revlon is up 22.6%, or…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
REV Revlon
$8.05 /

+1.48 (+22.53%)

REV Revlon
$8.05 /

+1.48 (+22.53%)

REV Revlon
$8.05 /

+1.48 (+22.53%)

REV Revlon
$8.05 /

+1.48 (+22.53%)

REV Revlon
$8.05 /

+1.48 (+22.53%)

Recommendations
Granite Real Estate price target raised to C$100 from C$99 at RBC Capital » 11:59
08/15/22
08/15
11:59
08/15/22
11:59
GRP

Granite Real Estate

$38.91 /

+ (+0.00%)

RBC Capital analyst Pammi…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
GRP Granite Real Estate
$38.91 /

+ (+0.00%)

11:37 Today National Bank
Granite Real Estate price target raised to C$90 from C$85 at National Bank
07/20/22 National Bank
Granite Real Estate price target lowered to C$85 from C$115 at National Bank
05/16/22 Desjardins
Granite Real Estate price target lowered to C$104 from C$111 at Desjardins
04/29/22 Scotiabank
Granite Real Estate price target raised to C$110 from C$109 at Scotiabank
Recommendations
Akouos files IND for AK-OTOF, says Piper Sandler » 11:59
08/15/22
08/15
11:59
08/15/22
11:59
AKUS

Akouos

$3.43 /

+0.35 (+11.36%)

Piper Sandler analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AKUS Akouos
$3.43 /

+0.35 (+11.36%)

AKUS Akouos
$3.43 /

+0.35 (+11.36%)

05/17/22 Piper Sandler
Akouos price target lowered to $18 from $40 at Piper Sandler
AKUS Akouos
$3.43 /

+0.35 (+11.36%)

AKUS Akouos
$3.43 /

+0.35 (+11.36%)

Recommendations
Exchange Income price target raised to C$63 from C$62 at RBC Capital » 11:59
08/15/22
08/15
11:59
08/15/22
11:59
EIFZF

Exchange Income

$38.22 /

+0.88 (+2.36%)

RBC Capital analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
EIFZF Exchange Income
$38.22 /

+0.88 (+2.36%)

11:36 Today National Bank
Exchange Income price target raised to C$61 from C$59 at National Bank
11:01 Today Scotiabank
Exchange Income price target raised to C$60 from C$56 at Scotiabank
10:52 Today TD Securities
Exchange Income price target raised to C$67 from C$59 at TD Securities
05/17/22 RBC Capital
Exchange Income price target raised to C$62 from C$52 at RBC Capital
Recommendations
ECN Capital price target raised to C$8 from C$7.50 at RBC Capital » 11:57
08/15/22
08/15
11:57
08/15/22
11:57
ECNCF

ECN Capital

$5.57 /

+0.384 (+7.40%)

RBC Capital analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ECNCF ECN Capital
$5.57 /

+0.384 (+7.40%)

08/12/22 BMO Capital
ECN Capital price target raised to C$8 from C$7 at BMO Capital
08/12/22 Raymond James
ECN Capital price target raised to C$8 from C$7 at Raymond James
08/12/22 National Bank
ECN Capital price target raised to C$8.50 from C$8 at National Bank
08/09/22 TD Securities
ECN Capital price target raised to C$8.50 from C$8 at TD Securities
Recommendations
Dialogue Health price target lowered to C$6 from C$7 at RBC Capital » 11:57
08/15/22
08/15
11:57
08/15/22
11:57
DLHTF

Dialogue Health

$2.30 /

+ (+0.00%)

RBC Capital analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
DLHTF Dialogue Health
$2.30 /

+ (+0.00%)

08/12/22 Scotiabank
Dialogue Health price target lowered to C$8 from C$8.50 at Scotiabank
08/12/22 TD Securities
Dialogue Health price target lowered to C$4.50 from C$5.50 at TD Securities
08/09/22 National Bank
Dialogue Health price target lowered to C$8.50 from C$11.50 at National Bank
Recommendations
Chemtrade Logistics price target raised to C$10 from C$9 at RBC Capital » 11:56
08/15/22
08/15
11:56
08/15/22
11:56
CGIFF

Chemtrade Logistics

$7.17 /

+0.06 (+0.84%)

RBC Capital analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CGIFF Chemtrade Logistics
$7.17 /

+0.06 (+0.84%)

11:34 Today National Bank
Chemtrade Logistics price target raised to C$11 from C$9.25 at National Bank
11:15 Today Desjardins
Chemtrade Logistics price target raised to C$11.75 from C$11 at Desjardins
08/12/22 BMO Capital
Chemtrade Logistics price target raised to C$9 from C$8 at BMO Capital
08/12/22 Scotiabank
Chemtrade Logistics price target raised to C$10.50 from C$10.25 at Scotiabank
Hot Stocks
Novartis' treatment of Malaria granted FDA orphan designation » 11:56
08/15/22
08/15
11:56
08/15/22
11:56
NVS

Novartis

$85.05 /

-0.63 (-0.74%)

Novartis…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
NVS Novartis
$85.05 /

-0.63 (-0.74%)

NVS Novartis
$85.05 /

-0.63 (-0.74%)

08/05/22 Truist
Global Blood could complement any oncology franchise, says Truist
08/04/22 Truist
Truist sees Novartis, Vertex as logical suitors for Global Blood
07/20/22 JPMorgan
Novartis price target raised to CHF 81 from CHF 80 at JPMorgan
07/20/22 Piper Sandler
Piper adjusts Ionis' Spinraza royalties estimate following Biogen report
NVS Novartis
$85.05 /

-0.63 (-0.74%)

NVS Novartis
$85.05 /

-0.63 (-0.74%)

NVS Novartis
$85.05 /

-0.63 (-0.74%)

NVS Novartis
$85.05 /

-0.63 (-0.74%)

Recommendations
AG Growth International price target raised to C$55 from C$50 at RBC Capital » 11:56
08/15/22
08/15
11:56
08/15/22
11:56
AGGZF

AG Growth International

$30.82 /

+1.01285 (+3.40%)

RBC Capital analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AGGZF AG Growth International
$30.82 /

+1.01285 (+3.40%)

11:11 Today Desjardins
AG Growth International price target raised to C$53 from C$48 at Desjardins
08/12/22 Scotiabank
AG Growth International price target raised to C$55 from C$52 at Scotiabank
04/20/22 Scotiabank
AG Growth International price target raised to C$52 from C$50 at Scotiabank
03/17/22 RBC Capital
AG Growth International price target raised to C$50 from C$45 at RBC Capital
Hot Stocks
Take-Two's Private Division to publish Middle-Earth game » 11:54
08/15/22
08/15
11:54
08/15/22
11:54
TTWO

Take-Two

$127.36 /

+4.22 (+3.43%)

Take-Two's Private…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
TTWO Take-Two
$127.36 /

+4.22 (+3.43%)

TTWO Take-Two
$127.36 /

+4.22 (+3.43%)

08/10/22 DZ Bank
Take-Two downgraded to Hold from Buy at DZ Bank
08/09/22 BofA
BofA downgrades Take-Two, says risk/reward less appealing after Zynga deal
08/09/22 BofA
Take-Two downgraded to Neutral from Buy at BofA
08/09/22 Oppenheimer
Take-Two price target lowered to $180 from $190 at Oppenheimer
TTWO Take-Two
$127.36 /

+4.22 (+3.43%)

TTWO Take-Two
$127.36 /

+4.22 (+3.43%)

TTWO Take-Two
$127.36 /

+4.22 (+3.43%)

TTWO Take-Two
$127.36 /

+4.22 (+3.43%)

Hot Stocks
Taseko Mines reports EPA issues draft permit for Florence Copper Project » 11:54
08/15/22
08/15
11:54
08/15/22
11:54
TGB

Taseko Mines

$1.20 /

+0.11 (+10.09%)

Taseko Mines announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TGB Taseko Mines
$1.20 /

+0.11 (+10.09%)

TGB Taseko Mines
$1.20 /

+0.11 (+10.09%)

08/10/22 Scotiabank
Taseko Mines price target lowered to C$1.75 from C$2 at Scotiabank
08/10/22 TD Securities
Taseko Mines price target lowered to C$2.25 from C$2.50 at TD Securities
08/09/22 BMO Capital
Taseko Mines price target lowered to C$2.50 from C$2.75 at BMO Capital
07/19/22 Stifel
Taseko Mines price target lowered to C$2.50 from C$3.40 at Stifel
TGB Taseko Mines
$1.20 /

+0.11 (+10.09%)

Recommendations
Viridian Therapeutics price target raised to $50 from $40 at Evercore ISI » 11:51
08/15/22
08/15
11:51
08/15/22
11:51
VRDN

Viridian Therapeutics

$23.74 /

+8.855 (+59.51%)

Evercore ISI analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
VRDN Viridian Therapeutics
$23.74 /

+8.855 (+59.51%)

VRDN Viridian Therapeutics
$23.74 /

+8.855 (+59.51%)

06/23/22 B. Riley
B. Riley starts Viridian Therapeutics at Buy with $25 price target
06/23/22 B. Riley
Viridian Therapeutics initiated with a Buy at B. Riley
11/18/21 SVB Leerink
Viridian Therapeutics initiated with an Outperform at SVB Leerink
11/05/21 JMP Securities
Viridian Therapeutics price target lowered to $36 from $44 at JMP Securities
VRDN Viridian Therapeutics
$23.74 /

+8.855 (+59.51%)

  • 21
    Sep
VRDN Viridian Therapeutics
$23.74 /

+8.855 (+59.51%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.